MithraGen Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
MithraGen General Information
Description
Developer of immunotherapies for T and B cells for the treatment and prevention of cancers and infectious diseases. The company develops immunotherapies incorporating Class I and II restricted epitopes for the treatment of cancers and infectious diseases that currently have no satisfactory therapy.
Contact Information
Website
www.mithragen.com
Formerly Known As
MithraTech
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Acquirer
Primary Office
- 8030 El Rio
- Houston, TX 77054
- United States
MithraGen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 01-Jan-2008 | 00.000 | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series B) | 12-Mar-2004 | 00.00 | 00.000 | 00.000 | Completed | Startup |
| 2. Early Stage VC (Series A) | $1.89M | $1.89M | 00.00 | Completed | ||
| 1. Accelerator/Incubator | Completed | Startup |
MithraGen Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A | 000,000 | 00.000000 | 00.00 | 00 | 00 | 00 | 00 | 00.000 |
MithraGen Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| BCM Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Emerging Technology Partners (Venture Capital) | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Wake Forest Baptist | Corporation | 000 0000 | 000000 0 |